新型即时检测方法测量脂蛋白(a)与实验室检测方法的比较
本研究将新型即时检测设备iProtin与Randox和Roche实验室检测方法进行比较,使用58份血清样本。结果显示iProtin与两种实验室方法均呈强相关性(R²分别为0.906和0.912),但日间和日内精密度存在一定变异。即时检测可能作为脂蛋白(a)实验室检测的补充选择,尤其适用于偏远地区。
要点
- iProtin即时检测设备与Randox和Roche实验室方法测量脂蛋白(a)相关性良好。
- iProtin日间精密度:低浓度质控15.5%,高浓度质控6.2%。
- 即时检测可作为脂蛋白(a)实验室检测的补充,尤其适用于偏远地区。
核心结论
- 即时检测设备iProtin与实验室检测方法测量脂蛋白(a)相关性良好,可作为实验室检测的补充选择。
研究设计与样本
- 使用58份残余患者血清样本,比较iProtin即时检测设备与Randox和Roche实验室检测方法测量脂蛋白(a)浓度,并评估iProtin的精密度和稀释性能。
主要发现
- iProtin与Randox的回归方程为1.15 × Randox + 7.28 nmol/L,R²为0.906。
- iProtin与Roche的回归方程为1.02 × Roche + 17.54 nmol/L,R²为0.912。
- Roche与Randox的回归方程为Roche=1.15 × Randox - 13.33 nmol/L,R²为0.973。
- iProtin日间精密度:低浓度质控15.5%,高浓度质控6.2%。
- iProtin日内精密度:低浓度患者样本13.2%,高浓度患者样本14.3%。
关键数值与推荐
- iProtin与Randox和Roche的R²值分别为0.906和0.912。
- iProtin日间不精密度:低浓度质控15.5%,高浓度质控6.2%。
- iProtin日内不精密度:低浓度患者样本13.2%,高浓度患者样本14.3%。
临床怎么用
- 即时检测可用于脂蛋白(a)检测,尤其在偏远地区,有助于心血管风险分层和治疗决策。
- 即时检测可作为实验室检测的补充选项,但需注意其精密度差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Lipoprotein(a) is an atherogenic particle causative of atherosclerotic cardiovascular disease. Novel treatments have been developed that lower lipoprotein(a) to unprecedented levels with cardiovascular outcomes trials ongoing. Many guidelines recommend testing once in the lifetime of everyone, but testing rates remain low. In this study we compare a lipoprotein(a) point of care testing device to laboratory analysers and assess its performance. METHODS: Lipoprotein(a) concentrations on residual patient samples measured on the Randox and Roche assays were compared to a novel point of care device, iProtin. Furthermore, assessment of iProtin performance characteristics were performed, including intra- and inter-assay coefficient of variation and dilutional studies. RESULTS: Lipoprotein(a) concentrations measured on the Randox and Roche assays showed strong correlation with iProtin. Regression analysis using Passing-Bablock showed the best fits for iProtin based on 58 serum samples were: 1.15 × Randox + 7.28 nmol/L and 1.02 × Roche + 17.54 nmol/L. The R2 values for Randox/iProtin and Roche/iProtin were 0.906 and 0.912 respectively. Correlation between Roche and Randox showed Roche=1.15 × Randox - 13.33 nmol/L with an R2 value of 0.973. Inter-assay coefficient of variation of the iProtin device showed a day-to-day imprecision over 5 days of 15.5 % (low concentration quality control) and 6.2 % (high concentration quality control). Within day imprecision was 13.2 % (lower concentration patient sample) and 14.3 % (higher concentration patient sample). CONCLUSIONS: Point of care testing could be a complimentary option to laboratory testing of lipoprotein(a), especially in remote areas. It may help (re-)stratify cardiovascular risk and help tailor treatment decisions.
引用
- Bachmeier CAE, Ward GJ, Kassianos AJ, et al. Measurement of lipoprotein(a) via a novel point of care approach with comparison to established laboratory assays. Clin Chem Lab Med. 2026. PMID: 41486066. doi:10.1515/cclm-2025-1605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。